GlassScriptPhysician profile
Dinesh Pubbi
NPI 1861454423
$25,521.37
in general payments reported to CMS, 2019-2025
48 companies · $2,599 in 2025
The $2,599 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,625 · 2020: $4,335 · 2021: $3,910 · 2022: $2,395 · 2023: $3,960 · 2024: $2,698 · 2025: $2,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,427 · Travel and Lodging: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,427.39 |
| Travel and Lodging | $828.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $6,815.18 | 2019-2024 | |
| Medtronic, INC. | $4,894.82 | 2021-2025 | Micra, Diamondtemp Bidirectional Ablation Catheter, Linq II |
| Medtronic Vascular, INC. | $2,883.10 | 2019-2020 | |
| Boston Scientific Corporation | $2,321.91 | 2019-2025 | Watchman Flx, Watchman Access System, Resonate El Icd Vr |
| Abbott Laboratories | $1,316.53 | 2019-2025 | Ensite Precision, Ensite, Jot Dx |
| E.R. Squibb & Sons, L.L.C. | $973.50 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $959.62 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $954.39 | 2020-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $772.50 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $488.30 | 2021-2025 | Verquvo, Capvaxive |
| Biosense Webster, INC. | $391.97 | 2019-2025 | Nuvision Ice Catheter, Qdot Micro Catheter, Carto 3 |
| Philips North America LLC | $374.13 | 2020-2025 | (Br5) Peripheral Ivus, Extended Holter, (Ck4) Mcot |
| Cvrx, INC. | $266.93 | 2020-2025 | Barostim Neo System |
| Pfizer INC. | $248.48 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $232.58 | 2019-2025 | Lifevest |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $231.53 | 2019-2022 | |
| Abiomed | $139.67 | 2025 | |
| Bard Peripheral Vascular, INC. | $111.25 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $99.51 | 2025 | Rhythm Express |
| Acutus Medical, INC. | $91.84 | 2022-2023 | |
| Cardiva Medical, INC. | $86.93 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Kestra Medical Technology Services, INC. | $86.03 | 2024-2025 | Assure Wcd |
| Medical Device Business Services, INC. | $70.10 | 2024 | Carto 3 |
| Irhythm Technologies, INC. | $61.76 | 2021-2023 | Zio Xt Patch |
| Amgen INC. | $54.93 | 2020-2024 | Repatha |
| Amarin Pharma, INC. | $48.33 | 2021 | |
| Genzyme Corporation | $46.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $44.62 | 2020-2025 | Farxiga |
| Esperion Therapeutics, INC. | $42.24 | 2021-2024 | Nexletol |
| Alnylam Pharmaceuticals INC. | $41.98 | 2021 | |
| Atricure, INC. | $30.92 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Cordis US Corp. | $29.20 | 2025 | Mynx Control Venous |
| Elutia, INC. | $27.58 | 2019-2023 | |
| United Therapeutics Corporation | $27.51 | 2025 | Tyvaso |
| Arbor Pharmaceuticals, INC. | $26.20 | 2019-2021 | |
| Bardy Diagnostics, INC. | $24.00 | 2019-2021 | |
| Celgene Corporation | $21.74 | 2025 | Eliquis |
| Biosig Technologies, INC. | $21.09 | 2021 | |
| Cleerly, INC. | $18.68 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Novo Nordisk INC | $18.68 | 2021 | |
| Lundbeck LLC | $18.40 | 2019 | |
| Impulse Dynamics (USA) INC. | $18.25 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.85 | 2021 | |
| Gilead Sciences, INC. | $15.70 | 2019 | |
| Heartflow, INC. | $15.48 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $15.02 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $12.92 | 2023 | Arcalyst |
| Cardiovascular Systems INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dinesh Pubbi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.